Apimeds Pharmaceuticals US's three largest insider shareholders as of July 24, 2026 are Inc. Inscobee (TenPercentOwner, 4.39Mn shares), Inc. Inscobee (TenPercentOwner, 2.10Mn shares), Jakap Koo (Director, 643.88K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Christopher Kim | Chairman And Cmo | 277,500 | 0 | 20 May, 2025 |
| Jakap Koo | - | 643,885 | 0 | 14 May, 2025 |
| Inc. Inscobee | - | 0 | 4,387,708 | 14 May, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 11 Nov, 2025 | Jakap Koo | Stock Option (right to buy) | A | 10,000 | $0.00 | 10,000 | D | A |
| 11 Nov, 2025 | Bennett Weintraub | Stock Option (right to buy) | A | 10,000 | $0.00 | 10,000 | D | A |
| 11 Nov, 2025 | Hankil Yoon | Stock Option (right to buy) | A | 10,000 | $0.00 | 10,000 | D | A |
| 11 Nov, 2025 | Jakap Koo | Stock Option (right to buy) | A | 10,000 | $0.00 | 10,000 | D | A |
| 11 Nov, 2025 | Carol A O'Donnell | Stock Option (right to buy) | A | 10,000 | $0.00 | 10,000 | D | A |
| 11 Nov, 2025 | Hankil Yoon | Stock Option (right to buy) | A | 10,000 | $0.00 | 10,000 | D | A |
| 11 Nov, 2025 | Hankil Yoon | Stock Option (right to buy) | A | 10,000 | $0.00 | 10,000 | D | A |
| 11 Nov, 2025 | Bennett Weintraub | Stock Option (right to buy) | A | 10,000 | $0.00 | 10,000 | D | A |
| 11 Nov, 2025 | Jakap Koo | Stock Option (right to buy) | A | 10,000 | $0.00 | 10,000 | D | A |
| 11 Nov, 2025 | Bennett Weintraub | Stock Option (right to buy) | A | 10,000 | $0.00 | 10,000 | D | A |
| 15 Oct, 2025 | Carol A O'Donnell | Stock Option (right to buy) | A | 3,000 | $0.00 | 3,000 | D | A |
| 15 Oct, 2025 | Bennett Weintraub | Stock Option (right to buy) | A | 3,000 | $0.00 | 3,000 | D | A |
| 15 Oct, 2025 | Christopher Kim | Stock Option (right to buy) | A | 3,000 | $0.00 | 3,000 | D | A |
| 15 Oct, 2025 | Jakap Koo | Stock Option (right to buy) | A | 3,000 | $0.00 | 3,000 | D | A |
| 15 Oct, 2025 | Christopher Kim | Stock Option (right to buy) | A | 3,000 | $0.00 | 3,000 | D | A |
| 15 Oct, 2025 | Jakap Koo | Stock Option (right to buy) | A | 3,000 | $0.00 | 3,000 | D | A |
| 15 Oct, 2025 | Hankil Yoon | Stock Option (right to buy) | A | 3,000 | $0.00 | 3,000 | D | A |
| 15 Oct, 2025 | Bennett Weintraub | Stock Option (right to buy) | A | 3,000 | $0.00 | 3,000 | D | A |
| 15 Oct, 2025 | Hankil Yoon | Stock Option (right to buy) | A | 3,000 | $0.00 | 3,000 | D | A |
| 15 Oct, 2025 | Bennett Weintraub | Stock Option (right to buy) | A | 3,000 | $0.00 | 3,000 | D | A |